Melior Discovery Is A Private Biopharmaceutical Company Located In Extonpennsylvaniafounded In 2005 By Drandrew Reaume And Drmichael Saporitothe Company Specializes In In Vivo Pharmacology Servicesfocusing On Drug Repositioning And The Development Of New Therapeutic Candidatesmelior Is Recognized For Its Proprietary Phenotypic Screening Platform Thera Tracea Which Aids In Identifying New Therapeutic Potentials For Drug Candidates The Company Offers A Variety Of Servicesincluding In Vivo Pharmacology Evaluations Across Over 80 Validated Animal Modelscontract Research Organizationcroservices Such As Pharmacokinetic Evaluations And Bioanalytical Testingand Drug Repositioning To Discover New Indications For Existing Drugsmelior Discovery Has Developed Its Own Pipeline Of Therapeutic Candidatesincluding Mlr 1023A Type 2 Diabetes Therapeutic That Received Fda Approval For An Investigational New Drug Application In 2009The Company Collaborates With Major Pharmaceutical Firms Like Pfizermerck & Co Johnson & Johnsonand Astrazenecaenhancing Its Capabilities In Drug Developmentin 2024Melior Was Named Contract Research Organization Of The Year By Life Sciences Review Magazine
No conferences found for this company.
| Company Name | Melior Discovery Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
